Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F3FM1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $73,797
Award facts
- Contract value 100% obligated
- $73,796.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $73,796.95 for SKYRIZI 150 MG/ML in pen/milliliter form on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the company's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic medication used to treat plaque psoriasis and other inflammatory conditions, representing the type of specialized pharmaceutical product that the Defense Logistics Agency procures to support military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, a $999,999,999 vehicle through December 31, 2031. As a major pharmaceutical distributor serving federal medical procurement needs, Cencora supplies a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The competitively awarded nature of this task order demonstrates the company's continued capability to meet federal procurement requirements in the highly competitive pharmaceutical supply market.
Quick answers
Who was awarded contract SPE2DR26F3FM1?
SPE2DR26F3FM1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F3FM1 worth?
The government has obligated $73,797 on SPE2DR26F3FM1.
Is contract SPE2DR26F3FM1 an order under another contract?
Yes. SPE2DR26F3FM1 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FM1 competed?
The extent of competition for SPE2DR26F3FM1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award